HealthEquity Inc. (NASDAQ:HQY) insider Jon Kessler sold 120,117 shares of the company’s stock in a transaction dated Monday, September 12th. The stock was sold at an average price of $33.10, for a total transaction of $3,975,872.70. Following the transaction, the insider now owns 476,561 shares in the company, valued at approximately $15,774,169.10. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Jon Kessler also recently made the following trade(s):

  • On Thursday, September 15th, Jon Kessler sold 20,000 shares of HealthEquity stock. The stock was sold at an average price of $33.46, for a total transaction of $669,200.00.
  • On Wednesday, August 31st, Jon Kessler sold 34,883 shares of HealthEquity stock. The stock was sold at an average price of $33.00, for a total transaction of $1,151,139.00.
  • On Monday, July 25th, Jon Kessler sold 10,000 shares of HealthEquity stock. The stock was sold at an average price of $29.62, for a total transaction of $296,200.00.
  • On Friday, July 15th, Jon Kessler sold 10,000 shares of HealthEquity stock. The stock was sold at an average price of $30.05, for a total transaction of $300,500.00.
  • On Thursday, June 23rd, Jon Kessler sold 10,000 shares of HealthEquity stock. The stock was sold at an average price of $29.00, for a total transaction of $290,000.00.

Shares of HealthEquity Inc. (NASDAQ:HQY) opened at 34.93 on Tuesday. HealthEquity Inc. has a 12 month low of $15.80 and a 12 month high of $35.78. The company has a 50 day moving average of $31.17 and a 200-day moving average of $27.61. The firm has a market capitalization of $2.05 billion, a P/E ratio of 89.56 and a beta of 1.65.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Tuesday, September 6th. The company reported $0.16 EPS for the quarter, topping the Zacks’ consensus estimate of $0.13 by $0.03. HealthEquity had a return on equity of 10.89% and a net margin of 15.21%. The company had revenue of $44.20 million for the quarter. During the same quarter in the previous year, the business posted $0.08 EPS. The firm’s revenue for the quarter was up 44.9% on a year-over-year basis. Analysts predict that HealthEquity Inc. will post $0.51 EPS for the current year.

Hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its position in HealthEquity by 26.3% in the second quarter. Vanguard Group Inc. now owns 3,150,828 shares of the company’s stock worth $95,739,000 after buying an additional 656,849 shares in the last quarter. Janus Capital Management LLC boosted its position in HealthEquity by 1.4% in the second quarter. Janus Capital Management LLC now owns 2,658,688 shares of the company’s stock worth $80,784,000 after buying an additional 37,044 shares in the last quarter. BlackRock Fund Advisors boosted its position in HealthEquity by 8.9% in the second quarter. BlackRock Fund Advisors now owns 2,619,987 shares of the company’s stock worth $79,608,000 after buying an additional 214,955 shares in the last quarter. Waddell & Reed Financial Inc. boosted its position in HealthEquity by 59.1% in the second quarter. Waddell & Reed Financial Inc. now owns 1,008,110 shares of the company’s stock worth $30,632,000 after buying an additional 374,529 shares in the last quarter. Finally, BlackRock Institutional Trust Company N.A. boosted its position in HealthEquity by 4.5% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 935,359 shares of the company’s stock worth $28,421,000 after buying an additional 40,512 shares in the last quarter. Institutional investors own 91.41% of the company’s stock.

Several research analysts recently issued reports on HQY shares. Zacks Investment Research upgraded shares of HealthEquity from a “hold” rating to a “buy” rating and set a $32.00 price target on the stock in a research report on Thursday, June 9th. Wells Fargo & Co. restated a “buy” rating on shares of HealthEquity in a research report on Wednesday, June 22nd. SunTrust Banks Inc. upped their target price on shares of HealthEquity from $34.00 to $40.00 and gave the company a “buy” rating in a research report on Wednesday, June 8th. Finally, TheStreet upgraded shares of HealthEquity from a “sell” rating to a “hold” rating in a research report on Tuesday, June 7th. Three research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $36.00.

HealthEquity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

5 Day Chart for NASDAQ:HQY

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.